NLRP3 and atherosclerosis: General risk factors for atherosclerosis are Ox-LDL, acrolein, and low shear stress, etc. Therefore, drugs or agents that target these NLRP3 inflammasome-related substances could be promising or preventing pyroptosis-related diseases such as atherosclerosis.